… A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. The
New England Journal of Medicine, 346(5), 321–327. https://doi.org/10.1056/NEJMoa011592. …

… a Prednisone dose ≥0.5 mg/kg per day applied during the autoimmune bullous
diseases (AIBDs) disease course. Values are expressed as number (percentage) or mean±standard …

… The ripple effect of the success of DCP therapy extended … Autoimmune bullous disorders,
characterized by blistering of … beneficiaries of corticosteroid pulse therapy. Additionally, …

… -epithelial autoimmune blistering diseases, most … corticosteroids are used in the treatment
of BP and can be applied to areas of blisters and erosions or even the whole body when used …

… , or pulse steroid therapy may be used 2 IVIg appears to be … with pemphigus and pemphigoid
through catabolism 6,7 … of various autoimmune and inflammatory diseases. Due to the …

… of life-threatening autoimmune bullous diseases characterized by blisters and erosions of
the … Systemic corticosteroid therapy (oral prednisone 1 to 1.5 mg/kg/day) alone or associated …

… most common subepidermal autoimmune blistering disease. … Ten patients were treated with
topical corticosteroid therapy … In conclusion, although BP is a bullous disease, a significant …

… Corticosteroid therapy was initiated resulting in remission of BP … rapid disease worsening
should be investigated for the development of a concomitant autoimmune blistering disease. …

… corticosteroids are often used as the first-line treatment. However, long-term corticosteroid
use … academic pursuits and the field of autoimmune bullous diseases. We are deeply grateful …

… the pemphigoid autoimmune blistering diseases, in which the body creates subepidermal
blisters … Oral steroids are tapered during this phase to minimize side effects and replaced with …